Stay updated on Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.

Latest updates to the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.5 replaces the previous v3.6.4 in the page footer, indicating a minor update to the Study Record History page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag has been updated to v3.6.4, indicating a minor version update. This metadata change does not modify the study record content or how the page functions for users.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new version entry (46) was added on 2026-06-30, updating the Study Status and Contacts/Locations and marking the revision as v3.6.3. The prior revision v3.6.2 was deleted on 2026-03-30.SummaryDifference0.4%

- Check44 days agoChange DetectedThe revision label in the page footer was updated from v3.6.0 to v3.6.2, indicating a newer build of the history page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe recruitment status text was updated to 'No longer looking for participants', indicating enrollment for this trial has closed. This reflects a shift in the study’s lifecycle where active enrollment is no longer ongoing.SummaryDifference0.2%

- Check65 days agoChange DetectedThe record history now shows Revision: v3.5.5 replacing the previous v3.5.4. This represents a minor update to the page's revision metadata.SummaryDifference0.1%

Stay in the know with updates to Belvarafenib in NRAS-Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belvarafenib in NRAS-Mutant Melanoma Clinical Trial page.